Concepedia

Keiko Ohga

KO

Statistics

Publications

11

Citations

637

H-Index

10

Active since

1998

Affiliations

Astellas Pharma (Japan)(Current)

Drug Discovery Laboratory (Norway)

Jichi Medical University

Keiko Ohga is an author at Astellas Pharma (Japan) specializing in pharmacology, immunology, and life sciences.

Publications per year

1998–2009

11

Publications

11

A Pyrazole Derivative, YM-58483, Potently Inhibits Store-Operated Sustained Ca2+ Influx and IL-2 Production in T Lymphocytes

Jun Ishikawa, Keiko Ohga, Taiji Yoshino et al. · The Journal of Immunology · 2003 · 254 citations · Full text

Life Sciences, Cell Biology, Pharmacology +17

YM-58483, a selective CRAC channel inhibitor, prevents antigen-induced airway eosinophilia and late phase asthmatic responses via Th2 cytokine inhibition in animal models

Taiji Yoshino, Jun Ishikawa, Keiko Ohga et al. · European Journal of Pharmacology · 2007 · 77 citations

Medicine, Immunology, Pharmacology +16

Characterization of YM-58483/BTP2, a novel store-operated Ca2+ entry blocker, on T cell-mediated immune responses in vivo

Keiko Ohga, Ryuichi Takezawa, Yasuhito Arakida et al. · International Immunopharmacology · 2008 · 76 citations

Life Sciences, Immunology, Pharmacology +14

Synthesis and evaluation of 2-{[2-(4-hydroxyphenyl)-ethyl]amino}pyrimidine-5-carboxamide derivatives as novel STAT6 inhibitors

S. Nagashima, Masaki Yokota, Eiichi Nakai et al. · Bioorganic & Medicinal Chemistry · 2006 · 61 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

The suppressive effects of YM-58483/BTP-2, a store-operated Ca2+ entry blocker, on inflammatory mediator release in vitro and airway responses in vivo

Keiko Ohga, Ryuichi Takezawa, Taiji Yoshino et al. · Pulmonary Pharmacology & Therapeutics · 2007 · 50 citations

Life Sciences, Immunology, Pharmacology +12

1–5 of 11